 Atea Pharmaceuticals, Inc. NASDAQ:AVIR Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Jonae Barnes - SVP, IR Corporate Communications Jean-Pierre Sommadossi - CEO and Founder John Vavricka - CCO Janet Hammond - CDO Andrea Corcoran - CFO and Executive President, Legal Conference Call Participants Hannah Adeoye - JPMorgan Matthew Harrison - Morgan Stanley Umer Raffat - Evercore Tim Lugo - William Blair Nik Gasic - SVB Securities Operator Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2022 Financial Results and Business Update Conference Call. 